The Middle East & Africa medical device adhesive market is expected to reach US$ 424.50 million by 2027 from US$ 270.93 million in 2019. The market is expected to grow at a CAGR of 5.8% during 2020–2027.
Increasing usage of medical device adhesive and technological advancements in medical device adhesive are driving the market in the region. Additionally, rapid surge in number of minimally invasive procedures and increasing adoption of eco-friendly and biocompatible solutions are likely to fuel the growth of the medical device adhesive market during the forecast period. However, factors such as complications associated with the medical device adhesive are likely to restrain the growth of the market.
Medical device adhesive are the adhesives that are manufactured as per the medical grades. They are mainly used for assembling medical devices. They also help to optimize assembly speeds to enable better processing, greater output as well as lowering the associated costs. During recent years, along with the technological developments in medical device industry, the demand for medical device adhesive has also increased significantly.
Continuous R&D studies are ongoing to gain a better understanding on creating high-end medical solutions for incorporating a wide range of medical devices in practical usage. Companies are investing in the development of innovative instruments to secure good return on investment (ROI). Additionally, the product approval by regulatory authorities confirms reliability and credibility of the new age medical device sealants and adhesives.
Recently, various market players have launched high-end and top-quality medical device adhesive in the market. For instance, the topical tissue adhesive, Topocryl from Heal & Care GmbH is unique as it can be used in various surgeries as a replacement or complementary to the physical sutures or stitches that are applied to close the wounds or cuts or lacerations. It is introduced in the Middle East and specifically as a first in UAE by Heal & Care in an exclusive arrangement with Best Star Pharma, Dubai to be made available to the medical fraternity. The mounting number of launches of such novel products facilitates the growth of the medical device adhesive market.
COVID-19 pandemic has become the most significant challenge in the region. This challenge will be especially frightening for the region’s fragile and conflict-torn states—such as Iraq (467,755), Sudan (13,772), Iran (596,941), Israel (313,114), and Yemen (2,062) as it will lead to reducing imports due to disruptions in global trade, which further increases the shortages of medical supplies and other goods, resulting in a considerable price increase. The Middle East countries have registered a growth in the number of COVID cases in the last few days, with the UAE registering 130,336 cases, Saudi Arabia reporting 346,482, and South Africa indicating 721,770 confirmed cases. However, the medical device adhesive market in this pandemic is on increasing due to the increased demand for respiratory treatments due to the outbreak of COVID-19. The countries mainly focused on the treatment of COVID-19 patients and hence looking for better treatment options. The impact of the COVID19 pandemic on the regional medical device adhesive market is moderate.
The acrylic segment held the largest share of the market in 2019, and is anticipated to register the highest CAGR in the market during the forecast period. Growth of this segment is attributed to the as evident use of acrylic solutions in wide range of applications such as dental, assembly of medical devices and equipment. Furthermore, medical grade acrylic is also ideal for use in interior and well as exterior medical applications that include skin tissue adhesives.
A few of the major secondary sources associated with the Middle East & Africa medical device adhesive market report include World Health Organization (WHO), Department of Global Health, International Diabetes Federation (IDF), Globocan, Population Reference Bureau MEA and others.